Company Filing History:
Years Active: 2014
Title: Lisel Vina Rodriguez: Innovator in Vaccine Development
Introduction
Lisel Vina Rodriguez is a prominent inventor based in Havana, Cuba. She has made significant contributions to the field of immunology, particularly in the development of vaccine compositions for cancer treatment. Her innovative approach has the potential to enhance therapeutic options for patients suffering from tumors.
Latest Patents
Lisel holds a patent for a groundbreaking method titled "Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors." This patent describes a vaccine composition that utilizes a chemical conjugate of human recombining Epidermic Growth Factor (hrEGF) and a combining protein P64k. The conjugation reaction produces this chemical conjugate in a controlled and reproducible manner. The preferred conjugate surprisingly increases immunogenic activity, leading to significant increases in anti-EGF antibody titers in humans. This innovative vaccine preparation allows for multiple effective dose presentations, enabling an increase in the immunization dose per patient without raising the frequency of immunizations or the number of immunization sites.
Career Highlights
Lisel is affiliated with the Centro de Inmunología Molecular (CIM), where she continues her research and development efforts. Her work is characterized by a commitment to advancing cancer treatment through innovative vaccine solutions.
Collaborations
Lisel collaborates with talented colleagues, including Gryssell Rodriguez Martinez and Loany Calvo Gonzalez. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Lisel Vina Rodriguez is a trailblazer in the field of vaccine development, with a focus on improving cancer treatment through innovative methods. Her contributions are paving the way for more effective therapeutic options for patients.